SONOMA PHARMACEUTICALS, INC. Accounts Payable and Other Accrued Liabilities
SONOMA PHARMACEUTICALS, INC. (SNOA) had Accounts Payable and Other Accrued Liabilities of $2.67 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:AccountsPayableAndOtherAccruedLiabilities · last filed 2026-08-06
- 2026-06-30: Accounts Payable and Other Accrued Liabilities $2.67M.
- 2026-03-31: Accounts Payable and Other Accrued Liabilities $2.25M.
- 2025-12-31: Accounts Payable and Other Accrued Liabilities $2.11M.
- 2025-09-30: Accounts Payable and Other Accrued Liabilities $2.02M.
| Period end | Accounts Payable and Other Accrued Liabilities | Accounts Payable and Other Accrued Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $2.67M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $2.25M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $2.11M 10-Q · filed 2026-02-10 | |
| 2025-09-30 | $2.02M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $1.84M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $2.22M 10-K · filed 2026-06-16 | |
| 2024-12-31 | $1.92M 10-Q · filed 2025-02-05 | |
| 2024-09-30 | $2.02M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $2.23M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $2.11M 10-K · filed 2025-06-17 | |
| 2023-12-31 | $1.85M 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $1.70M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $2.25M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.03M 10-K · filed 2024-06-17 | |
| 2022-12-31 | $2.20M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $1.79M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.95M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.84M 10-K · filed 2023-06-21 | |
| 2021-12-31 | $1.29M 10-Q · filed 2022-02-11 | |
| 2021-09-30 | $987.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.21M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $1.15M 10-K · filed 2022-07-13 | |
| 2020-12-31 | $1.05M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $932.00K 10-Q · filed 2020-11-20 | |
| 2020-06-30 | $918.00K 10-Q/A · filed 2020-11-17 | $743.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $1.77M 10-K · filed 2021-07-14 | |
| 2019-12-31 | $1.42M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $1.37M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.41M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $1.50M 10-K · filed 2020-07-10 | |
| 2018-12-31 | $1.53M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $1.24M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.61M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $1.41M 10-K · filed 2019-07-01 | |
| 2017-12-31 | $1.51M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $1.39M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $1.55M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $1.30M 10-K · filed 2018-06-26 | |
| 2016-12-31 | $1.63M 10-Q · filed 2017-02-17 | |
| 2016-09-30 | $1.19M 10-Q · filed 2016-11-15 | |
| 2016-06-30 | $1.44M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.53M 10-K · filed 2017-06-28 | |
| 2015-12-31 | $872.00K 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $1.02M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $916.00K 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $782.00K 10-K · filed 2016-06-21 | |
| 2014-12-31 | $833.00K 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $556.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $734.00K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $889.00K 10-K · filed 2015-06-16 | |
| 2013-12-31 | $588.00K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $699.00K 10-Q · filed 2013-11-19 | |
| 2013-06-30 | $648.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $703.00K 10-K · filed 2014-06-30 | |
| 2012-12-31 | $793.00K 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $765.00K 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $826.00K 10-Q/A · filed 2012-08-31 | |
| 2012-03-31 | $844.00K 10-K · filed 2013-06-25 | |
| 2011-12-31 | $679.00K 10-Q · filed 2012-02-10 | |
| 2011-03-31 | $694.00K 10-K · filed 2012-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |